Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$166M |
| 2 |
Tesla
TSLA
|
+$92.9M |
| 3 |
Roblox
RBLX
|
+$51.2M |
| 4 |
VICI Properties
VICI
|
+$42.8M |
| 5 |
Danaher
DHR
|
+$42.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$199M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$81.7M |
| 4 |
Canadian National Railway
CNI
|
+$56M |
| 5 |
Meta Platforms (Facebook)
META
|
+$44.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.43% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Aspen Aerogels
ASPN
$504M
| $693K | ﹤0.01% |
70,100
+7,500
| +12% | +$151K |
|
2527
Hyster-Yale Materials Handling
HY
$617M
| $690K | ﹤0.01% |
21,400
+4,500
| +27% | +$153K |
|
2528
PMV Pharmaceuticals
PMVP
$65.1M
| $687K | ﹤0.01% |
48,200
+21,400
| +80% | +$311K |
|
2529
CarParts.com
PRTS
$50.3M
| $687K | ﹤0.01% |
9,900
+590
| +6% | +$43.1K |
|
|
CWAN
2530
DELISTED
Clearwater Analytics
CWAN
| $685K | ﹤0.01% |
+56,900
| New | +$920K |
|
2531
Ramaco Resources Class A
METC
$667M
| $685K | ﹤0.01% |
+53,850
| New | +$810K |
|
|
AMPS
2532
DELISTED
Altus Power
AMPS
| $685K | ﹤0.01% |
+108,600
| New | +$725K |
|
2533
Cognyte Software
CGNT
$692M
| $675K | ﹤0.01% |
158,800
| – | – |
|
|
MMX
2534
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $674K | ﹤0.01% |
155,715
+34,200
| +28% | +$156K |
|
2535
Heron Therapeutics
HRTX
$63.5M
| $672K | ﹤0.01% |
240,700
+11,700
| +5% | +$47K |
|
2536
IES Holdings
IESC
$14.9B
| $670K | ﹤0.01% |
22,200
| – | – |
|
2537
Hagerty
HGTY
$1.32B
| $669K | ﹤0.01% |
+58,200
| New | +$589K |
|
2538
Protagonist Therapeutics
PTGX
$9.8B
| $667K | ﹤0.01% |
84,300
-17,200
| -17% | -$208K |
|
|
IAUX
2539
i-80 Gold Corp
IAUX
$1.43B
| $666K | ﹤0.01% |
+370,300
| New | +$874K |
|
2540
Organogenesis Holdings
ORGO
$226M
| $666K | ﹤0.01% |
136,400
+60,300
| +79% | +$371K |
|
|
GBIO
2541
DELISTED
Generation Bio
GBIO
| $661K | ﹤0.01% |
10,070
+1,330
| +15% | +$86.9K |
|
2542
Rush Enterprises Class B
RUSHB
$9.37B
| $655K | ﹤0.01% |
19,800
| – | – |
|
|
PNT
2543
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $651K | ﹤0.01% |
95,566
+10,400
| +12% | +$79.6K |
|
|
RXDX
2544
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $649K | ﹤0.01% |
23,000
-4,600
| -17% | -$133K |
|
2545
Forestar Group
FOR
$1.51B
| $641K | ﹤0.01% |
46,817
+5,800
| +14% | +$91.3K |
|
2546
Tredegar Corp
TG
$278M
| $639K | ﹤0.01% |
63,900
| – | – |
|
|
ROVR
2547
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $639K | ﹤0.01% |
169,900
-37,600
| -18% | -$194K |
|
|
ONTF
2548
DELISTED
ON24
ONTF
| $638K | ﹤0.01% |
67,200
+27,800
| +71% | +$337K |
|
2549
Alto Ingredients
ALTO
$326M
| $636K | ﹤0.01% |
171,500
+8,000
| +5% | +$41.8K |
|
2550
Skywest
SKYW
$4.21B
| $633K | ﹤0.01% |
29,800
| – | – |
|
Similar funds
Swiss National Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Swiss National Bank held 2,853 positions worth $148B, down 17% from $177B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2022 filing shows 162 new, 982 increased, 855 reduced and 113 closed positions. Its largest new stake was Roblox: 1,524,500 shares worth $50.1M. The largest sale was AT&T, an estimated $199M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2022 buy was Roblox: 1,524,500 shares worth $50.1M.
- Swiss National Bank added most to Warner Bros in Q2 2022, an estimated $166M increase.
- Swiss National Bank's biggest Q2 2022 reduction was AT&T, cutting an estimated $199M.
- Swiss National Bank fully exited Cerner Corp in Q2 2022, selling an estimated $119M.
- Swiss National Bank's ten largest holdings make up 25% of its $148B portfolio in Q2 2022.
- Swiss National Bank opened 162 new positions and closed 113 in Q2 2022.
- Swiss National Bank's portfolio value fell 17% quarter-over-quarter to $148B.
Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.